Effectiveness of Automated Insulin Management Features of the MiniMed® 640G Sensor-Augmented Insulin Pump

Diabetes Technology and Therapeutics

Volumn 18, Issue 10, 2016, Pages 657-663

  Zhong, Alex ^a   Choudhary, Pratik ^b   McMahon, Chantal ^a   Agrawal, Pratik ^a   Welsh, John B ^a   Cordero, Toni L ^a   Kaufman, Francine R ^a  

^a Medtronic   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; AUTOMATION; BLOOD GLUCOSE MONITORING; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; DATA ANALYSIS SOFTWARE; DRUG DELIVERY SYSTEM; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HYPERGLYCEMIA; INSULIN PUMP; NOCTURNAL HYPOGLYCEMIA; PLASMA CONCENTRATION-TIME CURVE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ANALYSIS; BLOOD; DIABETES MELLITUS, TYPE 1; HUMAN; INSULIN INFUSION; TREATMENT OUTCOME;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84992111563     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2016.0216     Document Type: Article

References (17)

1. Agrawal P, Welsh JB, Kannard B, et al.: Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump. J Diabetes Sci Technol 2011;5:1137-1141.
2. Agrawal P, Zhong A, Welsh JB, et al.: Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps. Diabetes Technol Ther 2015;17:316-319.
3. Choudhary P, Shin J, Wang Y, et al.: Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care 2011;34:2023-2025.
4. Danne T, Kordonouri O, Holder M, et al.: Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther 2011;13:1129-1134.
5. Elbarbary NS: Effectiveness of the low glucose suspend feature of insulin pump during fasting in Ramadan in type 1 diabetes mellitus. Diabetes Metab Res Rev 2016; doi: 10.1002/dmrr.2781.
6. Garg S, Brazg RL, Bailey TS, et al.: Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther 2012;14:205-209.
7. Pickup JC: Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps. Diabetes Technol Ther 2011;13:695-698.
8. Choudhary P, Olsen BS, Conget I, et al.: Hypoglycemia prevention and user acceptance of an insulin pump system with predictive low glucose management. Diabetes Technol Ther 2016;18:288-291.
9. de Bock MI, Roy A, Cooper MN, et al.: Feasibility of outpatient 24-hour closed-loop insulin delivery. Diabetes Care 2015;38:e186-e187.
10. Corriveau EA, Durso PJ, Kaufman ED, et al.: Effect of Carelink, an internet-based insulin pump monitoring system, on glycemic control in rural and urban children with type 1 diabetes mellitus. Pediatr Diabetes 2008;9:360-366.
11. Elliott L, Fidler C, Ditchfield A, et al.: Hypoglycemia event rates: a comparison between real-world data and randomized controlled trial populations in insulin-treated diabetes. Diabetes Ther 2016;7:45-60.
12. Nakamura K, Kent T, Hall T, et al.: Regular-life use of patient real-time CGM data. Diabetes 2015;64:A243.
13. Buckingham BA, Raghinaru D, Cameron F, et al.: Predictive low-glucose insulin suspension reduces duration of nocturnal hypoglycemia in children without increasing ketosis. Diabetes Care 2015;38:1197-1204.
14. Bailey T, Buckingham B, Christiansen M, et al.: In-clinic evaluation of a predictive low glucose management system (PLGM) for hypoglycemia prevention. Diabetes Technol Ther 2016;18(suppl 1):A24-A25.
15. Buckingham B, Chase HP, Dassau E, et al.: Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care 2010;33: 1013-1017.
16. Tauschmann M, Allen JM, Wilinska ME, et al.: Day-andnight hybrid closed-loop insulin delivery in adolescents with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care 2016;39:1168-1174.
17. Thabit H, Tauschmann M, Allen JM, et al.: Home Use of an Artificial Beta Cell in Type 1 Diabetes. N Engl J Med 2015;373:2129-2140.